|
AU3024399A
(en)
|
1998-04-03 |
1999-10-25 |
Bm Research A/S |
Controlled release composition
|
|
EP1429739A1
(en)
|
2001-09-21 |
2004-06-23 |
Egalet A/S |
Polymer release system
|
|
WO2003024430A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Morphine polymer release system
|
|
EP1929998A3
(en)
*
|
2001-09-21 |
2008-11-26 |
Egalet A/S |
Controlled release solid dispersions of carvedilol
|
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
JP2006500320A
(ja)
*
|
2002-04-30 |
2006-01-05 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
カルベジロール一クエン酸塩一水和物
|
|
AU2003251627A1
(en)
|
2002-06-27 |
2004-01-19 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol hydrobromide
|
|
MXPA04012923A
(es)
*
|
2002-06-27 |
2005-03-31 |
Sb Pharmco Inc |
Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento.
|
|
AU2003275953A1
(en)
*
|
2002-11-08 |
2004-06-07 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
US20060258652A1
(en)
*
|
2002-11-22 |
2006-11-16 |
Haj-Yehia Abdullah I |
Beta-blockers having antioxidant and no-donor activity
|
|
EP1610768B1
(en)
|
2003-03-26 |
2008-07-02 |
Egalet A/S |
Matrix compositions for controlled delivery of drug substances
|
|
EP1610767B1
(en)
|
2003-03-26 |
2011-01-19 |
Egalet A/S |
Morphine controlled release system
|
|
ATE445393T1
(de)
*
|
2003-04-24 |
2009-10-15 |
Jagotec Ag |
Tablette mit gefärbtem kern
|
|
US7260685B2
(en)
|
2003-06-20 |
2007-08-21 |
Micron Technology, Inc. |
Memory hub and access method having internal prefetch buffers
|
|
ES2401769T5
(es)
*
|
2003-09-12 |
2020-07-01 |
Amgen Inc |
Formulación de disolución rápida de cinacalcet HCl
|
|
US7120743B2
(en)
|
2003-10-20 |
2006-10-10 |
Micron Technology, Inc. |
Arbitration system and method for memory responses in a hub-based memory system
|
|
WO2005051322A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Sb Pharmco Puerto Rico Inc. |
Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
|
|
JP2007512372A
(ja)
|
2003-11-25 |
2007-05-17 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
カルベジロール塩、対応する組成物、送達および／または治療方法
|
|
US20050169994A1
(en)
*
|
2003-11-25 |
2005-08-04 |
Burke Matthew D. |
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
|
|
US20070196396A1
(en)
*
|
2004-02-11 |
2007-08-23 |
Rubicon Research Private Limited |
Controlled release pharmaceutical compositions with improved bioavailability
|
|
CA2611081C
(en)
*
|
2005-06-03 |
2016-05-31 |
Egalet A/S |
A drug delivery system for delivering active substances dispersed in a dispersion medium
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
US8703804B2
(en)
|
2006-03-26 |
2014-04-22 |
Uti Limited Partnership |
Ryanodine receptor inhibitors and methods relating thereto
|
|
SG174026A1
(en)
|
2006-08-03 |
2011-09-29 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid disease
|
|
US20080292695A1
(en)
*
|
2006-12-01 |
2008-11-27 |
Kristin Arnold |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
US20090028935A1
(en)
*
|
2006-12-01 |
2009-01-29 |
Kristin Arnold |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
EP2104493A2
(en)
*
|
2007-01-16 |
2009-09-30 |
Egalet A/S |
Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
WO2008114276A1
(en)
*
|
2007-03-16 |
2008-09-25 |
Lupin Limited |
Novel oral controlled release composition of carvedilol
|
|
BRPI0701904A2
(pt)
*
|
2007-04-27 |
2008-12-09 |
Libbs Farmaceutica Ltda |
forma farmacÊutica de liberaÇço controlada de princÍpios ativos com solubilidade dependente do baixo ph do meio e processo para preparar a forma farmacÊutica
|
|
AU2008258596B2
(en)
|
2007-06-04 |
2013-02-14 |
Egalet Ltd |
Controlled release pharmaceutical compositions for prolonged effect
|
|
AU2010207740B2
(en)
*
|
2009-01-26 |
2016-06-16 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of asthma
|
|
NZ594207A
(en)
|
2009-02-06 |
2013-03-28 |
Egalet Ltd |
Immediate release composition resistant to abuse by intake of alcohol
|
|
WO2010149169A2
(en)
|
2009-06-24 |
2010-12-29 |
Egalet A/S |
Controlled release formulations
|
|
TWI415604B
(zh)
*
|
2009-09-29 |
2013-11-21 |
Tsh Biopharm Corp Ltd |
調控釋放卡菲蒂羅劑型
|
|
TW201200165A
(en)
*
|
2010-02-22 |
2012-01-01 |
Daiichi Sankyo Co Ltd |
Oral solid extended release dosage form
|
|
ES2706880T3
(es)
|
2010-02-22 |
2019-04-01 |
Daiichi Sankyo Co Ltd |
Preparación sólida de liberación sostenida para uso oral
|
|
US9549899B2
(en)
|
2012-07-06 |
2017-01-24 |
Egalet Ltd. |
Abuse deterrent pharmaceutical compositions for controlled release
|
|
RU2665372C2
(ru)
|
2012-09-03 |
2018-08-29 |
Дайити Санкио Компани, Лимитед |
Пероральная фармацевтическая композиция замедленного высвобождения, содержащая гидрохлорид гидроморфона
|
|
KR102241487B1
(ko)
|
2013-02-20 |
2021-04-16 |
주식회사 종근당 |
제어방출 펠릿으로 된 약제학적 조성물
|
|
KR102158339B1
(ko)
|
2016-02-05 |
2020-09-21 |
삼진제약주식회사 |
인습성이 개선된 카르베딜롤 속방성 제제
|